House select committee tours ginkgo bioworks, previews biofab1, ginkgo's new integrated data generation facility set to launch in 2025

Members of congress visited ginkgo's boston seaport headquarters to discuss strategies for bolstering u.s. ability to compete in ai applications for biotechnology, as well as unlocking innovations in pharmaceuticals, agriculture, and across industries ginkgo's foundry generates essential data assets and tools to allow companies to more reliably develop biotech products  members also previewed ginkgo's new biofab1 facility, under construction in the seaport, which is expected to significantly increase ginkgo's r&d-for-service capacities when fully operational ginkgo's facilities in boston encompass 500,000+ sq. ft. of existing and planned capacity.
DNA Ratings Summary
DNA Quant Ranking